Treatment Resistant Schizophrenia Clinical Trials

2 recruiting trials for Treatment Resistant Schizophrenia. Eligibility criteria explained in plain English.

Total Trials

Recruiting Now

Phase 3 Trials

Recruiting Trials

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant...

Sponsor: Dr. Stavroula RakitziEnrolling: 401 location

RECRUITINGNCT06749444

Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia

Using a randomized controlled design, the project aims to test if cognitive behavioral therapy interventions specifically targeting sleep disorders can significantly lessen the...

Sponsor: Jimmi NielsenEnrolling: 601 location

Trial Phases

Phase 4: 1
Not Applicable: 1

Top Sponsors

Dr. Stavroula Rakitzi(1)
Jimmi Nielsen(1)

Interventions Being Tested

Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),(COMBINATION_PRODUCT, 1 trials)
Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,(COMBINATION_PRODUCT, 1 trials)
Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine(COMBINATION_PRODUCT, 1 trials)
Group D (Pharmacotherapy and TAU)Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, seropram, lithium, depakine)(COMBINATION_PRODUCT, 1 trials)
CBT-I(OTHER, 1 trials)
CBT(OTHER, 1 trials)